Seana  Carson net worth and biography

Seana Carson Biography and Net Worth

Seana Carson is General Counsel of Bausch Health. She joined Bausch Health in 2006, and served as Senior Vice President and Chief Compliance Officer for more than 12 years. In 2019 she was named Senior Vice President, Head of Legal International, with responsibility for the international legal function. Before joining Bausch Health, Seana began her career as an Associate with the Norton Rose Fulbright international legal firm. Seana received her law degree from Queens University in Ontario and a bachelor’s degree from the University of Western Ontario.

What is Seana Carson's net worth?

The estimated net worth of Seana Carson is at least $3.69 million as of September 6th, 2024. Ms. Carson owns 435,198 shares of Bausch Health Companies stock worth more than $3,690,479 as of November 17th. This net worth estimate does not reflect any other assets that Ms. Carson may own. Additionally, Ms. Carson receives a salary of $872,650.00 as EVP at Bausch Health Companies. Learn More about Seana Carson's net worth.

How old is Seana Carson?

Ms. Carson is currently 51 years old. There are 2 older executives and no younger executives at Bausch Health Companies. The oldest executive at Bausch Health Companies is Mr. Thomas J. Appio, CEO & Director, who is 62 years old. Learn More on Seana Carson's age.

What is Seana Carson's salary?

As the EVP of Bausch Health Companies Inc., Ms. Carson earns $872,650.00 per year. The highest earning executive at Bausch Health Companies is Mr. Thomas J. Appio, CEO & Director, who commands a salary of $2,740,000.00 per year. Learn More on Seana Carson's salary.

How do I contact Seana Carson?

The corporate mailing address for Ms. Carson and other Bausch Health Companies executives is 2150 ST. ELZEAR BLVD. WEST, LAVAL A8, H7L 4A8. Bausch Health Companies can also be reached via phone at (514) 744-6792 and via email at [email protected]. Learn More on Seana Carson's contact information.

Has Seana Carson been buying or selling shares of Bausch Health Companies?

Seana Carson has not been actively trading shares of Bausch Health Companies during the last quarter. Most recently, Seana Carson sold 13,370 shares of the business's stock in a transaction on Friday, September 6th. The shares were sold at an average price of $6.21, for a transaction totalling $83,027.70. Following the completion of the sale, the executive vice president now directly owns 435,198 shares of the company's stock, valued at $2,702,579.58. Learn More on Seana Carson's trading history.

Who are Bausch Health Companies' active insiders?

Bausch Health Companies' insider roster includes Christina Ackermann (EVP), Seana Carson (EVP), Richard DeSchutter (Director), Sam Eldessouky (CFO), Joseph Gordon (Insider), William Humphries (Insider), Steven Miller (Director), Robert Spurr (Insider), and Amy Wechsler (Director). Learn More on Bausch Health Companies' active insiders.

Are insiders buying or selling shares of Bausch Health Companies?

In the last year, insiders at the sold shares 2 times. They sold a total of 13,590 shares worth more than $84,651.30. The most recent insider tranaction occured on September, 6th when EVP Seana Carson sold 13,370 shares worth more than $83,027.70. Insiders at Bausch Health Companies own 8.1% of the company. Learn More about insider trades at Bausch Health Companies.

Information on this page was last updated on 9/6/2024.

Seana Carson Insider Trading History at Bausch Health Companies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/6/2024Sell13,370$6.21$83,027.70435,198View SEC Filing Icon  
12/5/2023Sell220$7.38$1,623.60382,925View SEC Filing Icon  
11/6/2023Sell43$7.61$327.23384,836View SEC Filing Icon  
9/6/2023Sell6,685$8.28$55,351.80385,213View SEC Filing Icon  
2/28/2023Sell292$9.32$2,721.44359,185View SEC Filing Icon  
See Full Table

Seana Carson Buying and Selling Activity at Bausch Health Companies

This chart shows Seana Carson's buying and selling at Bausch Health Companies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bausch Health Companies Company Overview

Bausch Health Companies logo
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Read More

Today's Range

Now: $8.48
Low: $8.47
High: $8.73

50 Day Range

MA: $8.18
Low: $6.19
High: $9.78

2 Week Range

Now: $8.48
Low: $3.96
High: $11.46

Volume

1,027,632 shs

Average Volume

2,020,304 shs

Market Capitalization

$3.12 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74